nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—schizophrenia—Lamotrigine—epilepsy syndrome	0.0927	0.332	CpDpCtD
Trifluoperazine—CHRM2—epilepsy syndrome	0.0764	0.547	CbGaD
Trifluoperazine—schizophrenia—Carbamazepine—epilepsy syndrome	0.0702	0.252	CpDpCtD
Trifluoperazine—UGT1A4—Lamotrigine—epilepsy syndrome	0.0657	0.336	CbGbCtD
Trifluoperazine—schizophrenia—Valproic Acid—epilepsy syndrome	0.0597	0.214	CpDpCtD
Trifluoperazine—schizophrenia—Clonazepam—epilepsy syndrome	0.0562	0.201	CpDpCtD
Trifluoperazine—UGT1A4—Midazolam—epilepsy syndrome	0.0446	0.228	CbGbCtD
Trifluoperazine—HTR2A—epilepsy syndrome	0.0382	0.274	CbGaD
Trifluoperazine—UGT1A4—Valproic Acid—epilepsy syndrome	0.0338	0.173	CbGbCtD
Trifluoperazine—ABCB1—epilepsy syndrome	0.025	0.179	CbGaD
Trifluoperazine—Pirenzepine—Oxcarbazepine—epilepsy syndrome	0.024	0.114	CrCrCtD
Trifluoperazine—Loxapine—Clobazam—epilepsy syndrome	0.0141	0.0667	CrCrCtD
Trifluoperazine—Clozapine—Clonazepam—epilepsy syndrome	0.0133	0.0627	CrCrCtD
Trifluoperazine—Loxapine—Diazepam—epilepsy syndrome	0.0131	0.062	CrCrCtD
Trifluoperazine—Clozapine—Clobazam—epilepsy syndrome	0.0121	0.0573	CrCrCtD
Trifluoperazine—Ethopropazine—Carbamazepine—epilepsy syndrome	0.0121	0.0571	CrCrCtD
Trifluoperazine—Clozapine—Diazepam—epilepsy syndrome	0.0113	0.0533	CrCrCtD
Trifluoperazine—Methdilazine—Carbamazepine—epilepsy syndrome	0.0106	0.0502	CrCrCtD
Trifluoperazine—Clomipramine—Clobazam—epilepsy syndrome	0.0102	0.0482	CrCrCtD
Trifluoperazine—Promethazine—Carbamazepine—epilepsy syndrome	0.01	0.0473	CrCrCtD
Trifluoperazine—Alimemazine—Carbamazepine—epilepsy syndrome	0.00984	0.0465	CrCrCtD
Trifluoperazine—Methdilazine—Oxcarbazepine—epilepsy syndrome	0.00978	0.0462	CrCrCtD
Trifluoperazine—Clomipramine—Diazepam—epilepsy syndrome	0.00948	0.0448	CrCrCtD
Trifluoperazine—Promethazine—Oxcarbazepine—epilepsy syndrome	0.00923	0.0436	CrCrCtD
Trifluoperazine—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.00906	0.0428	CrCrCtD
Trifluoperazine—Chlorpromazine—Clobazam—epilepsy syndrome	0.00902	0.0426	CrCrCtD
Trifluoperazine—Promazine—Carbamazepine—epilepsy syndrome	0.00848	0.0401	CrCrCtD
Trifluoperazine—Prochlorperazine—Clobazam—epilepsy syndrome	0.0081	0.0383	CrCrCtD
Trifluoperazine—Promazine—Oxcarbazepine—epilepsy syndrome	0.00781	0.0369	CrCrCtD
Trifluoperazine—ABCB1—Levetiracetam—epilepsy syndrome	0.00644	0.0329	CbGbCtD
Trifluoperazine—ABCB1—Clobazam—epilepsy syndrome	0.00447	0.0228	CbGbCtD
Trifluoperazine—ABCB1—Lamotrigine—epilepsy syndrome	0.0043	0.022	CbGbCtD
Trifluoperazine—CYP1A2—Carbamazepine—epilepsy syndrome	0.00423	0.0216	CbGbCtD
Trifluoperazine—CYP1A2—Primidone—epilepsy syndrome	0.00395	0.0202	CbGbCtD
Trifluoperazine—ABCB1—Carbamazepine—epilepsy syndrome	0.0037	0.0189	CbGbCtD
Trifluoperazine—CYP1A2—Propofol—epilepsy syndrome	0.00354	0.0181	CbGbCtD
Trifluoperazine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00338	0.0173	CbGbCtD
Trifluoperazine—ABCB1—Phenytoin—epilepsy syndrome	0.00332	0.0169	CbGbCtD
Trifluoperazine—CYP1A2—Diazepam—epilepsy syndrome	0.00321	0.0164	CbGbCtD
Trifluoperazine—ABCB1—Phenobarbital—epilepsy syndrome	0.00296	0.0151	CbGbCtD
Trifluoperazine—ABCB1—Midazolam—epilepsy syndrome	0.00292	0.0149	CbGbCtD
Trifluoperazine—ABCB1—Diazepam—epilepsy syndrome	0.0028	0.0143	CbGbCtD
Trifluoperazine—CYP1A2—Valproic Acid—epilepsy syndrome	0.00253	0.0129	CbGbCtD
Trifluoperazine—HTR2A—phrenic nerve—epilepsy syndrome	0.00164	0.0515	CbGeAlD
Trifluoperazine—HTR6—ganglion—epilepsy syndrome	0.000745	0.0234	CbGeAlD
Trifluoperazine—HTR2A—locus ceruleus—epilepsy syndrome	0.000731	0.023	CbGeAlD
Trifluoperazine—S100A4—Bortezomib—Lacosamide—epilepsy syndrome	0.000703	0.752	CbGdCrCtD
Trifluoperazine—CALM2—pons—epilepsy syndrome	0.000695	0.0219	CbGeAlD
Trifluoperazine—CALM1—pons—epilepsy syndrome	0.000692	0.0218	CbGeAlD
Trifluoperazine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000691	0.0217	CbGeAlD
Trifluoperazine—CALM1—autonomic nervous system—epilepsy syndrome	0.000638	0.0201	CbGeAlD
Trifluoperazine—HTR2A—cerebellar cortex—epilepsy syndrome	0.000596	0.0187	CbGeAlD
Trifluoperazine—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000582	0.0183	CbGeAlD
Trifluoperazine—CALM2—ear—epilepsy syndrome	0.000573	0.018	CbGeAlD
Trifluoperazine—CALM1—ear—epilepsy syndrome	0.00057	0.0179	CbGeAlD
Trifluoperazine—HTR2A—vagus nerve—epilepsy syndrome	0.00056	0.0176	CbGeAlD
Trifluoperazine—CALY—telencephalon—epilepsy syndrome	0.000553	0.0174	CbGeAlD
Trifluoperazine—DRD2—telencephalic ventricle—epilepsy syndrome	0.000526	0.0165	CbGeAlD
Trifluoperazine—CALY—medulla oblongata—epilepsy syndrome	0.000434	0.0137	CbGeAlD
Trifluoperazine—HTR2C—ganglion—epilepsy syndrome	0.00043	0.0135	CbGeAlD
Trifluoperazine—HTR2A—pons—epilepsy syndrome	0.000421	0.0133	CbGeAlD
Trifluoperazine—CALY—midbrain—epilepsy syndrome	0.000397	0.0125	CbGeAlD
Trifluoperazine—HTR2A—autonomic nervous system—epilepsy syndrome	0.000389	0.0122	CbGeAlD
Trifluoperazine—CALY—spinal cord—epilepsy syndrome	0.000387	0.0122	CbGeAlD
Trifluoperazine—EBPL—head—epilepsy syndrome	0.000376	0.0118	CbGeAlD
Trifluoperazine—S100A4—medulla oblongata—epilepsy syndrome	0.000375	0.0118	CbGeAlD
Trifluoperazine—HTR1A—ganglion—epilepsy syndrome	0.000362	0.0114	CbGeAlD
Trifluoperazine—EBPL—nervous system—epilepsy syndrome	0.000357	0.0112	CbGeAlD
Trifluoperazine—CALM2—ganglion—epilepsy syndrome	0.000356	0.0112	CbGeAlD
Trifluoperazine—CALM1—ganglion—epilepsy syndrome	0.000354	0.0111	CbGeAlD
Trifluoperazine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000347	0.0109	CbGeAlD
Trifluoperazine—CALY—head—epilepsy syndrome	0.000344	0.0108	CbGeAlD
Trifluoperazine—EBPL—central nervous system—epilepsy syndrome	0.000343	0.0108	CbGeAlD
Trifluoperazine—S100A4—midbrain—epilepsy syndrome	0.000343	0.0108	CbGeAlD
Trifluoperazine—EBPL—cerebellum—epilepsy syndrome	0.000336	0.0106	CbGeAlD
Trifluoperazine—S100A4—spinal cord—epilepsy syndrome	0.000334	0.0105	CbGeAlD
Trifluoperazine—DRD2—ganglion—epilepsy syndrome	0.000327	0.0103	CbGeAlD
Trifluoperazine—CALY—nervous system—epilepsy syndrome	0.000326	0.0103	CbGeAlD
Trifluoperazine—CALY—central nervous system—epilepsy syndrome	0.000314	0.00988	CbGeAlD
Trifluoperazine—HTR6—forebrain—epilepsy syndrome	0.000312	0.00982	CbGeAlD
Trifluoperazine—CALY—cerebellum—epilepsy syndrome	0.000307	0.00965	CbGeAlD
Trifluoperazine—S100A4—head—epilepsy syndrome	0.000297	0.00934	CbGeAlD
Trifluoperazine—HTR6—telencephalon—epilepsy syndrome	0.000287	0.00903	CbGeAlD
Trifluoperazine—HTR1A—hindbrain—epilepsy syndrome	0.000275	0.00864	CbGeAlD
Trifluoperazine—EBPL—brain—epilepsy syndrome	0.000273	0.00857	CbGeAlD
Trifluoperazine—CALM2—hindbrain—epilepsy syndrome	0.00027	0.00849	CbGeAlD
Trifluoperazine—CALM1—hindbrain—epilepsy syndrome	0.000269	0.00845	CbGeAlD
Trifluoperazine—S100A4—cerebellum—epilepsy syndrome	0.000265	0.00833	CbGeAlD
Trifluoperazine—ADRA1A—hindbrain—epilepsy syndrome	0.000253	0.00796	CbGeAlD
Trifluoperazine—CALY—brain—epilepsy syndrome	0.000249	0.00784	CbGeAlD
Trifluoperazine—DRD2—hindbrain—epilepsy syndrome	0.000248	0.0078	CbGeAlD
Trifluoperazine—EBP—Bortezomib—Lacosamide—epilepsy syndrome	0.000232	0.248	CbGdCrCtD
Trifluoperazine—HTR2A—ganglion—epilepsy syndrome	0.000216	0.00679	CbGeAlD
Trifluoperazine—S100A4—brain—epilepsy syndrome	0.000215	0.00677	CbGeAlD
Trifluoperazine—CHRM2—forebrain—epilepsy syndrome	0.000187	0.00589	CbGeAlD
Trifluoperazine—HTR2C—brainstem—epilepsy syndrome	0.000187	0.00588	CbGeAlD
Trifluoperazine—HTR2C—forebrain—epilepsy syndrome	0.000181	0.00568	CbGeAlD
Trifluoperazine—HTR6—head—epilepsy syndrome	0.000179	0.00562	CbGeAlD
Trifluoperazine—CALM3—telencephalon—epilepsy syndrome	0.000175	0.0055	CbGeAlD
Trifluoperazine—CHRM2—telencephalon—epilepsy syndrome	0.000172	0.00541	CbGeAlD
Trifluoperazine—HTR6—nervous system—epilepsy syndrome	0.00017	0.00533	CbGeAlD
Trifluoperazine—HTR2C—telencephalon—epilepsy syndrome	0.000166	0.00522	CbGeAlD
Trifluoperazine—HTR2A—hindbrain—epilepsy syndrome	0.000164	0.00515	CbGeAlD
Trifluoperazine—HTR6—central nervous system—epilepsy syndrome	0.000163	0.00513	CbGeAlD
Trifluoperazine—HTR1A—brainstem—epilepsy syndrome	0.000157	0.00495	CbGeAlD
Trifluoperazine—SIGMAR1—telencephalon—epilepsy syndrome	0.000156	0.00491	CbGeAlD
Trifluoperazine—CALM2—brainstem—epilepsy syndrome	0.000155	0.00487	CbGeAlD
Trifluoperazine—CALM1—brainstem—epilepsy syndrome	0.000154	0.00484	CbGeAlD
Trifluoperazine—HTR1A—forebrain—epilepsy syndrome	0.000152	0.00478	CbGeAlD
Trifluoperazine—CALM2—forebrain—epilepsy syndrome	0.000149	0.0047	CbGeAlD
Trifluoperazine—CALM1—forebrain—epilepsy syndrome	0.000149	0.00467	CbGeAlD
Trifluoperazine—ADRA1A—brainstem—epilepsy syndrome	0.000145	0.00456	CbGeAlD
Trifluoperazine—DRD2—brainstem—epilepsy syndrome	0.000142	0.00447	CbGeAlD
Trifluoperazine—ADRA1A—forebrain—epilepsy syndrome	0.00014	0.0044	CbGeAlD
Trifluoperazine—HTR1A—telencephalon—epilepsy syndrome	0.00014	0.00439	CbGeAlD
Trifluoperazine—CALM3—medulla oblongata—epilepsy syndrome	0.000137	0.00432	CbGeAlD
Trifluoperazine—CALM2—telencephalon—epilepsy syndrome	0.000137	0.00432	CbGeAlD
Trifluoperazine—DRD2—forebrain—epilepsy syndrome	0.000137	0.00432	CbGeAlD
Trifluoperazine—CALM1—telencephalon—epilepsy syndrome	0.000137	0.0043	CbGeAlD
Trifluoperazine—HTR2C—medulla oblongata—epilepsy syndrome	0.00013	0.0041	CbGeAlD
Trifluoperazine—HTR6—brain—epilepsy syndrome	0.00013	0.00408	CbGeAlD
Trifluoperazine—ADRA1A—telencephalon—epilepsy syndrome	0.000129	0.00405	CbGeAlD
Trifluoperazine—DRD2—telencephalon—epilepsy syndrome	0.000126	0.00397	CbGeAlD
Trifluoperazine—CALM3—midbrain—epilepsy syndrome	0.000126	0.00395	CbGeAlD
Trifluoperazine—SIGMAR1—medulla oblongata—epilepsy syndrome	0.000123	0.00386	CbGeAlD
Trifluoperazine—CALM3—spinal cord—epilepsy syndrome	0.000123	0.00385	CbGeAlD
Trifluoperazine—HTR2C—midbrain—epilepsy syndrome	0.000119	0.00375	CbGeAlD
Trifluoperazine—HTR2C—spinal cord—epilepsy syndrome	0.000116	0.00366	CbGeAlD
Trifluoperazine—SIGMAR1—midbrain—epilepsy syndrome	0.000112	0.00353	CbGeAlD
Trifluoperazine—SIGMAR1—spinal cord—epilepsy syndrome	0.000109	0.00344	CbGeAlD
Trifluoperazine—HRH1—forebrain—epilepsy syndrome	0.000108	0.00341	CbGeAlD
Trifluoperazine—CALM2—medulla oblongata—epilepsy syndrome	0.000108	0.00339	CbGeAlD
Trifluoperazine—CALM1—medulla oblongata—epilepsy syndrome	0.000107	0.00338	CbGeAlD
Trifluoperazine—CHRM2—head—epilepsy syndrome	0.000107	0.00337	CbGeAlD
Trifluoperazine—HTR2C—head—epilepsy syndrome	0.000103	0.00325	CbGeAlD
Trifluoperazine—CHRM2—nervous system—epilepsy syndrome	0.000102	0.0032	CbGeAlD
Trifluoperazine—HTR1A—midbrain—epilepsy syndrome	0.0001	0.00315	CbGeAlD
Trifluoperazine—HRH1—telencephalon—epilepsy syndrome	9.97e-05	0.00313	CbGeAlD
Trifluoperazine—CALM2—midbrain—epilepsy syndrome	9.86e-05	0.0031	CbGeAlD
Trifluoperazine—CALM1—midbrain—epilepsy syndrome	9.82e-05	0.00309	CbGeAlD
Trifluoperazine—HTR2C—nervous system—epilepsy syndrome	9.8e-05	0.00308	CbGeAlD
Trifluoperazine—HTR1A—spinal cord—epilepsy syndrome	9.79e-05	0.00308	CbGeAlD
Trifluoperazine—CHRM2—central nervous system—epilepsy syndrome	9.79e-05	0.00308	CbGeAlD
Trifluoperazine—CALM3—cerebellum—epilepsy syndrome	9.71e-05	0.00305	CbGeAlD
Trifluoperazine—CALM2—spinal cord—epilepsy syndrome	9.62e-05	0.00303	CbGeAlD
Trifluoperazine—CALM1—spinal cord—epilepsy syndrome	9.58e-05	0.00301	CbGeAlD
Trifluoperazine—HTR2C—central nervous system—epilepsy syndrome	9.43e-05	0.00297	CbGeAlD
Trifluoperazine—HTR2A—brainstem—epilepsy syndrome	9.38e-05	0.00295	CbGeAlD
Trifluoperazine—DRD2—midbrain—epilepsy syndrome	9.07e-05	0.00285	CbGeAlD
Trifluoperazine—HTR2A—forebrain—epilepsy syndrome	9.06e-05	0.00285	CbGeAlD
Trifluoperazine—Pirenzepine—CHRM1—epilepsy syndrome	8.89e-05	0.0389	CrCbGaD
Trifluoperazine—HTR1A—head—epilepsy syndrome	8.7e-05	0.00274	CbGeAlD
Trifluoperazine—SIGMAR1—cerebellum—epilepsy syndrome	8.68e-05	0.00273	CbGeAlD
Trifluoperazine—CALM2—head—epilepsy syndrome	8.55e-05	0.00269	CbGeAlD
Trifluoperazine—CALM1—head—epilepsy syndrome	8.51e-05	0.00268	CbGeAlD
Trifluoperazine—HTR2A—telencephalon—epilepsy syndrome	8.33e-05	0.00262	CbGeAlD
Trifluoperazine—HTR1A—nervous system—epilepsy syndrome	8.25e-05	0.00259	CbGeAlD
Trifluoperazine—CALM2—nervous system—epilepsy syndrome	8.11e-05	0.00255	CbGeAlD
Trifluoperazine—CALM1—nervous system—epilepsy syndrome	8.07e-05	0.00254	CbGeAlD
Trifluoperazine—ADRA1A—head—epilepsy syndrome	8.02e-05	0.00252	CbGeAlD
Trifluoperazine—HTR1A—central nervous system—epilepsy syndrome	7.94e-05	0.0025	CbGeAlD
Trifluoperazine—CALM3—brain—epilepsy syndrome	7.89e-05	0.00248	CbGeAlD
Trifluoperazine—DRD2—head—epilepsy syndrome	7.86e-05	0.00247	CbGeAlD
Trifluoperazine—CALM2—central nervous system—epilepsy syndrome	7.81e-05	0.00245	CbGeAlD
Trifluoperazine—CHRM2—brain—epilepsy syndrome	7.77e-05	0.00244	CbGeAlD
Trifluoperazine—CALM1—central nervous system—epilepsy syndrome	7.77e-05	0.00244	CbGeAlD
Trifluoperazine—HTR1A—cerebellum—epilepsy syndrome	7.76e-05	0.00244	CbGeAlD
Trifluoperazine—CALM2—cerebellum—epilepsy syndrome	7.63e-05	0.0024	CbGeAlD
Trifluoperazine—ADRA1A—nervous system—epilepsy syndrome	7.6e-05	0.00239	CbGeAlD
Trifluoperazine—CALM1—cerebellum—epilepsy syndrome	7.59e-05	0.00239	CbGeAlD
Trifluoperazine—HTR2C—brain—epilepsy syndrome	7.49e-05	0.00236	CbGeAlD
Trifluoperazine—DRD2—nervous system—epilepsy syndrome	7.45e-05	0.00234	CbGeAlD
Trifluoperazine—ADRA1A—central nervous system—epilepsy syndrome	7.32e-05	0.0023	CbGeAlD
Trifluoperazine—DRD2—central nervous system—epilepsy syndrome	7.18e-05	0.00226	CbGeAlD
Trifluoperazine—ADRA1A—cerebellum—epilepsy syndrome	7.16e-05	0.00225	CbGeAlD
Trifluoperazine—SIGMAR1—brain—epilepsy syndrome	7.05e-05	0.00222	CbGeAlD
Trifluoperazine—DRD2—cerebellum—epilepsy syndrome	7.01e-05	0.00221	CbGeAlD
Trifluoperazine—Flupentixol—CHRM1—epilepsy syndrome	6.9e-05	0.0302	CrCbGaD
Trifluoperazine—HTR2A—medulla oblongata—epilepsy syndrome	6.54e-05	0.00206	CbGeAlD
Trifluoperazine—HTR1A—brain—epilepsy syndrome	6.3e-05	0.00198	CbGeAlD
Trifluoperazine—HRH1—head—epilepsy syndrome	6.21e-05	0.00195	CbGeAlD
Trifluoperazine—CALM2—brain—epilepsy syndrome	6.2e-05	0.00195	CbGeAlD
Trifluoperazine—CALM1—brain—epilepsy syndrome	6.17e-05	0.00194	CbGeAlD
Trifluoperazine—HTR2A—midbrain—epilepsy syndrome	5.98e-05	0.00188	CbGeAlD
Trifluoperazine—ABCB1—forebrain—epilepsy syndrome	5.93e-05	0.00187	CbGeAlD
Trifluoperazine—HRH1—nervous system—epilepsy syndrome	5.89e-05	0.00185	CbGeAlD
Trifluoperazine—HTR2A—spinal cord—epilepsy syndrome	5.83e-05	0.00183	CbGeAlD
Trifluoperazine—ADRA1A—brain—epilepsy syndrome	5.81e-05	0.00183	CbGeAlD
Trifluoperazine—DRD2—brain—epilepsy syndrome	5.7e-05	0.00179	CbGeAlD
Trifluoperazine—HRH1—central nervous system—epilepsy syndrome	5.67e-05	0.00178	CbGeAlD
Trifluoperazine—ABCB1—telencephalon—epilepsy syndrome	5.46e-05	0.00172	CbGeAlD
Trifluoperazine—HTR2A—head—epilepsy syndrome	5.19e-05	0.00163	CbGeAlD
Trifluoperazine—HTR2A—nervous system—epilepsy syndrome	4.92e-05	0.00155	CbGeAlD
Trifluoperazine—HTR2A—central nervous system—epilepsy syndrome	4.73e-05	0.00149	CbGeAlD
Trifluoperazine—HTR2A—cerebellum—epilepsy syndrome	4.63e-05	0.00145	CbGeAlD
Trifluoperazine—Ethopropazine—CHRM1—epilepsy syndrome	4.59e-05	0.0201	CrCbGaD
Trifluoperazine—HRH1—brain—epilepsy syndrome	4.5e-05	0.00141	CbGeAlD
Trifluoperazine—Cyamemazine—CHRM2—epilepsy syndrome	4.42e-05	0.0193	CrCbGaD
Trifluoperazine—ABCB1—medulla oblongata—epilepsy syndrome	4.29e-05	0.00135	CbGeAlD
Trifluoperazine—Antrafenine—PTGS2—epilepsy syndrome	4.09e-05	0.0179	CrCbGaD
Trifluoperazine—ABCB1—midbrain—epilepsy syndrome	3.92e-05	0.00123	CbGeAlD
Trifluoperazine—Mequitazine—CHRM2—epilepsy syndrome	3.84e-05	0.0168	CrCbGaD
Trifluoperazine—ABCB1—spinal cord—epilepsy syndrome	3.82e-05	0.0012	CbGeAlD
Trifluoperazine—Propericiazine—ADRA2A—epilepsy syndrome	3.77e-05	0.0165	CrCbGaD
Trifluoperazine—HTR2A—brain—epilepsy syndrome	3.76e-05	0.00118	CbGeAlD
Trifluoperazine—Triflupromazine—CHRM1—epilepsy syndrome	3.76e-05	0.0164	CrCbGaD
Trifluoperazine—Ethopropazine—CHRM2—epilepsy syndrome	3.74e-05	0.0164	CrCbGaD
Trifluoperazine—Constipation—Phenytoin—epilepsy syndrome	3.61e-05	0.000439	CcSEcCtD
Trifluoperazine—Asthenia—Levetiracetam—epilepsy syndrome	3.6e-05	0.000439	CcSEcCtD
Trifluoperazine—Pancytopenia—Topiramate—epilepsy syndrome	3.6e-05	0.000439	CcSEcCtD
Trifluoperazine—Pruritus—Midazolam—epilepsy syndrome	3.6e-05	0.000438	CcSEcCtD
Trifluoperazine—Dyspnoea—Carbamazepine—epilepsy syndrome	3.59e-05	0.000437	CcSEcCtD
Trifluoperazine—Constipation—Oxcarbazepine—epilepsy syndrome	3.59e-05	0.000437	CcSEcCtD
Trifluoperazine—Somnolence—Carbamazepine—epilepsy syndrome	3.58e-05	0.000436	CcSEcCtD
Trifluoperazine—Urticaria—Felbamate—epilepsy syndrome	3.58e-05	0.000436	CcSEcCtD
Trifluoperazine—Vision blurred—Valproic Acid—epilepsy syndrome	3.57e-05	0.000435	CcSEcCtD
Trifluoperazine—Body temperature increased—Felbamate—epilepsy syndrome	3.56e-05	0.000434	CcSEcCtD
Trifluoperazine—Oedema peripheral—Gabapentin—epilepsy syndrome	3.55e-05	0.000433	CcSEcCtD
Trifluoperazine—Pruritus—Levetiracetam—epilepsy syndrome	3.55e-05	0.000433	CcSEcCtD
Trifluoperazine—Tremor—Valproic Acid—epilepsy syndrome	3.55e-05	0.000433	CcSEcCtD
Trifluoperazine—Insomnia—Lamotrigine—epilepsy syndrome	3.52e-05	0.000429	CcSEcCtD
Trifluoperazine—Headache—Acetazolamide—epilepsy syndrome	3.5e-05	0.000427	CcSEcCtD
Trifluoperazine—Urticaria—Zonisamide—epilepsy syndrome	3.5e-05	0.000426	CcSEcCtD
Trifluoperazine—Decreased appetite—Carbamazepine—epilepsy syndrome	3.5e-05	0.000426	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Topiramate—epilepsy syndrome	3.49e-05	0.000426	CcSEcCtD
Trifluoperazine—Body temperature increased—Zonisamide—epilepsy syndrome	3.48e-05	0.000424	CcSEcCtD
Trifluoperazine—Agitation—Valproic Acid—epilepsy syndrome	3.48e-05	0.000424	CcSEcCtD
Trifluoperazine—Hypersensitivity—Vigabatrin—epilepsy syndrome	3.48e-05	0.000424	CcSEcCtD
Trifluoperazine—Asthenia—Fosphenytoin—epilepsy syndrome	3.48e-05	0.000424	CcSEcCtD
Trifluoperazine—Fatigue—Carbamazepine—epilepsy syndrome	3.47e-05	0.000423	CcSEcCtD
Trifluoperazine—Dyspnoea—Lamotrigine—epilepsy syndrome	3.47e-05	0.000423	CcSEcCtD
Trifluoperazine—Angioedema—Valproic Acid—epilepsy syndrome	3.46e-05	0.000422	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Topiramate—epilepsy syndrome	3.46e-05	0.000422	CcSEcCtD
Trifluoperazine—Somnolence—Lamotrigine—epilepsy syndrome	3.46e-05	0.000422	CcSEcCtD
Trifluoperazine—Weight increased—Topiramate—epilepsy syndrome	3.45e-05	0.000421	CcSEcCtD
Trifluoperazine—Clozapine—HRH3—epilepsy syndrome	3.45e-05	0.0151	CrCbGaD
Trifluoperazine—Constipation—Carbamazepine—epilepsy syndrome	3.44e-05	0.00042	CcSEcCtD
Trifluoperazine—Dizziness—Propofol—epilepsy syndrome	3.44e-05	0.000419	CcSEcCtD
Trifluoperazine—Pruritus—Fosphenytoin—epilepsy syndrome	3.43e-05	0.000418	CcSEcCtD
Trifluoperazine—Hypersensitivity—Diazepam—epilepsy syndrome	3.43e-05	0.000418	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Topiramate—epilepsy syndrome	3.42e-05	0.000417	CcSEcCtD
Trifluoperazine—ABCB1—head—epilepsy syndrome	3.4e-05	0.00107	CbGeAlD
Trifluoperazine—Leukopenia—Valproic Acid—epilepsy syndrome	3.39e-05	0.000413	CcSEcCtD
Trifluoperazine—Asthenia—Vigabatrin—epilepsy syndrome	3.39e-05	0.000413	CcSEcCtD
Trifluoperazine—Decreased appetite—Lamotrigine—epilepsy syndrome	3.38e-05	0.000412	CcSEcCtD
Trifluoperazine—Urticaria—Clonazepam—epilepsy syndrome	3.37e-05	0.000411	CcSEcCtD
Trifluoperazine—Dizziness—Midazolam—epilepsy syndrome	3.36e-05	0.00041	CcSEcCtD
Trifluoperazine—Body temperature increased—Clonazepam—epilepsy syndrome	3.36e-05	0.000409	CcSEcCtD
Trifluoperazine—Fatigue—Lamotrigine—epilepsy syndrome	3.35e-05	0.000409	CcSEcCtD
Trifluoperazine—Urticaria—Phenytoin—epilepsy syndrome	3.35e-05	0.000408	CcSEcCtD
Trifluoperazine—Pruritus—Vigabatrin—epilepsy syndrome	3.34e-05	0.000407	CcSEcCtD
Trifluoperazine—Asthenia—Diazepam—epilepsy syndrome	3.34e-05	0.000407	CcSEcCtD
Trifluoperazine—Body temperature increased—Phenytoin—epilepsy syndrome	3.33e-05	0.000406	CcSEcCtD
Trifluoperazine—Urticaria—Oxcarbazepine—epilepsy syndrome	3.33e-05	0.000406	CcSEcCtD
Trifluoperazine—Constipation—Lamotrigine—epilepsy syndrome	3.33e-05	0.000405	CcSEcCtD
Trifluoperazine—Nervousness—Pregabalin—epilepsy syndrome	3.33e-05	0.000405	CcSEcCtD
Trifluoperazine—Nausea—Acetazolamide—epilepsy syndrome	3.32e-05	0.000405	CcSEcCtD
Trifluoperazine—Dizziness—Levetiracetam—epilepsy syndrome	3.32e-05	0.000405	CcSEcCtD
Trifluoperazine—Body temperature increased—Oxcarbazepine—epilepsy syndrome	3.32e-05	0.000404	CcSEcCtD
Trifluoperazine—Cough—Valproic Acid—epilepsy syndrome	3.31e-05	0.000403	CcSEcCtD
Trifluoperazine—Muscle spasms—Pregabalin—epilepsy syndrome	3.29e-05	0.000401	CcSEcCtD
Trifluoperazine—Pruritus—Diazepam—epilepsy syndrome	3.29e-05	0.000401	CcSEcCtD
Trifluoperazine—Rash—Propofol—epilepsy syndrome	3.28e-05	0.000399	CcSEcCtD
Trifluoperazine—Dermatitis—Propofol—epilepsy syndrome	3.27e-05	0.000399	CcSEcCtD
Trifluoperazine—Headache—Propofol—epilepsy syndrome	3.26e-05	0.000397	CcSEcCtD
Trifluoperazine—Hypersensitivity—Zonisamide—epilepsy syndrome	3.25e-05	0.000396	CcSEcCtD
Trifluoperazine—Asthenia—Felbamate—epilepsy syndrome	3.23e-05	0.000394	CcSEcCtD
Trifluoperazine—Vision blurred—Pregabalin—epilepsy syndrome	3.23e-05	0.000393	CcSEcCtD
Trifluoperazine—ABCB1—nervous system—epilepsy syndrome	3.22e-05	0.00101	CbGeAlD
Trifluoperazine—Tremor—Pregabalin—epilepsy syndrome	3.21e-05	0.000391	CcSEcCtD
Trifluoperazine—Rash—Midazolam—epilepsy syndrome	3.21e-05	0.000391	CcSEcCtD
Trifluoperazine—Dizziness—Fosphenytoin—epilepsy syndrome	3.2e-05	0.00039	CcSEcCtD
Trifluoperazine—Dermatitis—Midazolam—epilepsy syndrome	3.2e-05	0.00039	CcSEcCtD
Trifluoperazine—Urticaria—Carbamazepine—epilepsy syndrome	3.2e-05	0.00039	CcSEcCtD
Trifluoperazine—Headache—Midazolam—epilepsy syndrome	3.18e-05	0.000388	CcSEcCtD
Trifluoperazine—Pruritus—Felbamate—epilepsy syndrome	3.18e-05	0.000388	CcSEcCtD
Trifluoperazine—Body temperature increased—Carbamazepine—epilepsy syndrome	3.18e-05	0.000388	CcSEcCtD
Trifluoperazine—Rash—Levetiracetam—epilepsy syndrome	3.17e-05	0.000386	CcSEcCtD
Trifluoperazine—Dermatitis—Levetiracetam—epilepsy syndrome	3.16e-05	0.000385	CcSEcCtD
Trifluoperazine—Asthenia—Zonisamide—epilepsy syndrome	3.16e-05	0.000385	CcSEcCtD
Trifluoperazine—Agranulocytosis—Topiramate—epilepsy syndrome	3.15e-05	0.000384	CcSEcCtD
Trifluoperazine—Dry mouth—Valproic Acid—epilepsy syndrome	3.15e-05	0.000384	CcSEcCtD
Trifluoperazine—Agitation—Pregabalin—epilepsy syndrome	3.15e-05	0.000384	CcSEcCtD
Trifluoperazine—Headache—Levetiracetam—epilepsy syndrome	3.15e-05	0.000383	CcSEcCtD
Trifluoperazine—Erythema—Gabapentin—epilepsy syndrome	3.14e-05	0.000383	CcSEcCtD
Trifluoperazine—Angioedema—Pregabalin—epilepsy syndrome	3.13e-05	0.000381	CcSEcCtD
Trifluoperazine—Hypersensitivity—Clonazepam—epilepsy syndrome	3.13e-05	0.000381	CcSEcCtD
Trifluoperazine—Ethopropazine—BCHE—epilepsy syndrome	3.12e-05	0.0137	CrCbGaD
Trifluoperazine—Dizziness—Vigabatrin—epilepsy syndrome	3.12e-05	0.000381	CcSEcCtD
Trifluoperazine—Pruritus—Zonisamide—epilepsy syndrome	3.12e-05	0.00038	CcSEcCtD
Trifluoperazine—Hypersensitivity—Phenytoin—epilepsy syndrome	3.11e-05	0.000379	CcSEcCtD
Trifluoperazine—ABCB1—central nervous system—epilepsy syndrome	3.1e-05	0.000975	CbGeAlD
Trifluoperazine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	3.09e-05	0.000377	CcSEcCtD
Trifluoperazine—Urticaria—Lamotrigine—epilepsy syndrome	3.09e-05	0.000377	CcSEcCtD
Trifluoperazine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	3.09e-05	0.000377	CcSEcCtD
Trifluoperazine—Nausea—Propofol—epilepsy syndrome	3.09e-05	0.000376	CcSEcCtD
Trifluoperazine—Body temperature increased—Lamotrigine—epilepsy syndrome	3.08e-05	0.000375	CcSEcCtD
Trifluoperazine—Dizziness—Diazepam—epilepsy syndrome	3.07e-05	0.000375	CcSEcCtD
Trifluoperazine—Triflupromazine—CHRM2—epilepsy syndrome	3.07e-05	0.0134	CrCbGaD
Trifluoperazine—Leukopenia—Pregabalin—epilepsy syndrome	3.07e-05	0.000374	CcSEcCtD
Trifluoperazine—Rash—Fosphenytoin—epilepsy syndrome	3.05e-05	0.000372	CcSEcCtD
Trifluoperazine—Dermatitis—Fosphenytoin—epilepsy syndrome	3.05e-05	0.000372	CcSEcCtD
Trifluoperazine—Nervousness—Gabapentin—epilepsy syndrome	3.05e-05	0.000372	CcSEcCtD
Trifluoperazine—Asthenia—Clonazepam—epilepsy syndrome	3.05e-05	0.000371	CcSEcCtD
Trifluoperazine—Headache—Fosphenytoin—epilepsy syndrome	3.04e-05	0.00037	CcSEcCtD
Trifluoperazine—ABCB1—cerebellum—epilepsy syndrome	3.03e-05	0.000953	CbGeAlD
Trifluoperazine—Asthenia—Phenytoin—epilepsy syndrome	3.03e-05	0.000369	CcSEcCtD
Trifluoperazine—Nausea—Midazolam—epilepsy syndrome	3.02e-05	0.000368	CcSEcCtD
Trifluoperazine—Muscle spasms—Gabapentin—epilepsy syndrome	3.02e-05	0.000368	CcSEcCtD
Trifluoperazine—Asthenia—Oxcarbazepine—epilepsy syndrome	3.01e-05	0.000367	CcSEcCtD
Trifluoperazine—Pruritus—Clonazepam—epilepsy syndrome	3e-05	0.000366	CcSEcCtD
Trifluoperazine—Skin disorder—Valproic Acid—epilepsy syndrome	3e-05	0.000366	CcSEcCtD
Trifluoperazine—Oedema peripheral—Topiramate—epilepsy syndrome	2.99e-05	0.000364	CcSEcCtD
Trifluoperazine—Cough—Pregabalin—epilepsy syndrome	2.99e-05	0.000364	CcSEcCtD
Trifluoperazine—Pruritus—Phenytoin—epilepsy syndrome	2.98e-05	0.000364	CcSEcCtD
Trifluoperazine—Nausea—Levetiracetam—epilepsy syndrome	2.98e-05	0.000363	CcSEcCtD
Trifluoperazine—Propiomazine—CHRM3—epilepsy syndrome	2.98e-05	0.013	CrCbGaD
Trifluoperazine—Rash—Vigabatrin—epilepsy syndrome	2.98e-05	0.000363	CcSEcCtD
Trifluoperazine—Dizziness—Felbamate—epilepsy syndrome	2.98e-05	0.000363	CcSEcCtD
Trifluoperazine—Dermatitis—Vigabatrin—epilepsy syndrome	2.98e-05	0.000363	CcSEcCtD
Trifluoperazine—Pruritus—Oxcarbazepine—epilepsy syndrome	2.97e-05	0.000362	CcSEcCtD
Trifluoperazine—Convulsion—Pregabalin—epilepsy syndrome	2.97e-05	0.000362	CcSEcCtD
Trifluoperazine—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.97e-05	0.000361	CcSEcCtD
Trifluoperazine—Vision blurred—Gabapentin—epilepsy syndrome	2.96e-05	0.000361	CcSEcCtD
Trifluoperazine—Headache—Vigabatrin—epilepsy syndrome	2.96e-05	0.000361	CcSEcCtD
Trifluoperazine—Anorexia—Valproic Acid—epilepsy syndrome	2.95e-05	0.000359	CcSEcCtD
Trifluoperazine—Tremor—Gabapentin—epilepsy syndrome	2.94e-05	0.000359	CcSEcCtD
Trifluoperazine—Rash—Diazepam—epilepsy syndrome	2.93e-05	0.000357	CcSEcCtD
Trifluoperazine—Dermatitis—Diazepam—epilepsy syndrome	2.93e-05	0.000357	CcSEcCtD
Trifluoperazine—Dizziness—Zonisamide—epilepsy syndrome	2.91e-05	0.000355	CcSEcCtD
Trifluoperazine—Headache—Diazepam—epilepsy syndrome	2.91e-05	0.000355	CcSEcCtD
Trifluoperazine—Hypotension—Valproic Acid—epilepsy syndrome	2.89e-05	0.000352	CcSEcCtD
Trifluoperazine—Asthenia—Carbamazepine—epilepsy syndrome	2.89e-05	0.000352	CcSEcCtD
Trifluoperazine—Agitation—Gabapentin—epilepsy syndrome	2.89e-05	0.000352	CcSEcCtD
Trifluoperazine—Nausea—Fosphenytoin—epilepsy syndrome	2.88e-05	0.000351	CcSEcCtD
Trifluoperazine—Angioedema—Gabapentin—epilepsy syndrome	2.87e-05	0.00035	CcSEcCtD
Trifluoperazine—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.87e-05	0.000349	CcSEcCtD
Trifluoperazine—Dry mouth—Pregabalin—epilepsy syndrome	2.85e-05	0.000347	CcSEcCtD
Trifluoperazine—Pruritus—Carbamazepine—epilepsy syndrome	2.85e-05	0.000347	CcSEcCtD
Trifluoperazine—Rash—Felbamate—epilepsy syndrome	2.84e-05	0.000346	CcSEcCtD
Trifluoperazine—Dermatitis—Felbamate—epilepsy syndrome	2.83e-05	0.000345	CcSEcCtD
Trifluoperazine—Headache—Felbamate—epilepsy syndrome	2.82e-05	0.000344	CcSEcCtD
Trifluoperazine—Flupentixol—HTR2A—epilepsy syndrome	2.82e-05	0.0123	CrCbGaD
Trifluoperazine—Leukopenia—Gabapentin—epilepsy syndrome	2.81e-05	0.000343	CcSEcCtD
Trifluoperazine—Dizziness—Clonazepam—epilepsy syndrome	2.81e-05	0.000342	CcSEcCtD
Trifluoperazine—Nausea—Vigabatrin—epilepsy syndrome	2.81e-05	0.000342	CcSEcCtD
Trifluoperazine—Insomnia—Valproic Acid—epilepsy syndrome	2.8e-05	0.000341	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.79e-05	0.000341	CcSEcCtD
Trifluoperazine—Asthenia—Lamotrigine—epilepsy syndrome	2.79e-05	0.00034	CcSEcCtD
Trifluoperazine—Dizziness—Phenytoin—epilepsy syndrome	2.79e-05	0.00034	CcSEcCtD
Trifluoperazine—Propiomazine—CHRM1—epilepsy syndrome	2.78e-05	0.0122	CrCbGaD
Trifluoperazine—Rash—Zonisamide—epilepsy syndrome	2.78e-05	0.000339	CcSEcCtD
Trifluoperazine—Dermatitis—Zonisamide—epilepsy syndrome	2.77e-05	0.000338	CcSEcCtD
Trifluoperazine—Dizziness—Oxcarbazepine—epilepsy syndrome	2.77e-05	0.000338	CcSEcCtD
Trifluoperazine—Nausea—Diazepam—epilepsy syndrome	2.76e-05	0.000337	CcSEcCtD
Trifluoperazine—Headache—Zonisamide—epilepsy syndrome	2.76e-05	0.000336	CcSEcCtD
Trifluoperazine—Dyspnoea—Valproic Acid—epilepsy syndrome	2.76e-05	0.000336	CcSEcCtD
Trifluoperazine—Pruritus—Lamotrigine—epilepsy syndrome	2.75e-05	0.000335	CcSEcCtD
Trifluoperazine—Somnolence—Valproic Acid—epilepsy syndrome	2.75e-05	0.000335	CcSEcCtD
Trifluoperazine—Cough—Gabapentin—epilepsy syndrome	2.74e-05	0.000334	CcSEcCtD
Trifluoperazine—Convulsion—Gabapentin—epilepsy syndrome	2.72e-05	0.000332	CcSEcCtD
Trifluoperazine—Skin disorder—Pregabalin—epilepsy syndrome	2.71e-05	0.000331	CcSEcCtD
Trifluoperazine—Zuclopenthixol—ADRA2A—epilepsy syndrome	2.7e-05	0.0118	CrCbGaD
Trifluoperazine—Mesoridazine—CHRM2—epilepsy syndrome	2.69e-05	0.0118	CrCbGaD
Trifluoperazine—Decreased appetite—Valproic Acid—epilepsy syndrome	2.69e-05	0.000328	CcSEcCtD
Trifluoperazine—Nefazodone—ADRA2A—epilepsy syndrome	2.69e-05	0.0118	CrCbGaD
Trifluoperazine—Rash—Clonazepam—epilepsy syndrome	2.68e-05	0.000326	CcSEcCtD
Trifluoperazine—Dermatitis—Clonazepam—epilepsy syndrome	2.67e-05	0.000326	CcSEcCtD
Trifluoperazine—Nausea—Felbamate—epilepsy syndrome	2.67e-05	0.000326	CcSEcCtD
Trifluoperazine—Fatigue—Valproic Acid—epilepsy syndrome	2.67e-05	0.000325	CcSEcCtD
Trifluoperazine—Anorexia—Pregabalin—epilepsy syndrome	2.66e-05	0.000325	CcSEcCtD
Trifluoperazine—Dizziness—Carbamazepine—epilepsy syndrome	2.66e-05	0.000324	CcSEcCtD
Trifluoperazine—Headache—Clonazepam—epilepsy syndrome	2.66e-05	0.000324	CcSEcCtD
Trifluoperazine—Rash—Phenytoin—epilepsy syndrome	2.66e-05	0.000324	CcSEcCtD
Trifluoperazine—Dermatitis—Phenytoin—epilepsy syndrome	2.66e-05	0.000324	CcSEcCtD
Trifluoperazine—Rash—Oxcarbazepine—epilepsy syndrome	2.64e-05	0.000322	CcSEcCtD
Trifluoperazine—Constipation—Valproic Acid—epilepsy syndrome	2.64e-05	0.000322	CcSEcCtD
Trifluoperazine—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.64e-05	0.000322	CcSEcCtD
Trifluoperazine—Headache—Phenytoin—epilepsy syndrome	2.64e-05	0.000322	CcSEcCtD
Trifluoperazine—Erythema—Topiramate—epilepsy syndrome	2.64e-05	0.000322	CcSEcCtD
Trifluoperazine—Headache—Oxcarbazepine—epilepsy syndrome	2.63e-05	0.00032	CcSEcCtD
Trifluoperazine—Nausea—Zonisamide—epilepsy syndrome	2.62e-05	0.000319	CcSEcCtD
Trifluoperazine—Dry mouth—Gabapentin—epilepsy syndrome	2.61e-05	0.000319	CcSEcCtD
Trifluoperazine—Hypotension—Pregabalin—epilepsy syndrome	2.61e-05	0.000318	CcSEcCtD
Trifluoperazine—Prochlorperazine—CHRM2—epilepsy syndrome	2.61e-05	0.0114	CrCbGaD
Trifluoperazine—Dizziness—Lamotrigine—epilepsy syndrome	2.57e-05	0.000314	CcSEcCtD
Trifluoperazine—Nervousness—Topiramate—epilepsy syndrome	2.57e-05	0.000313	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.56e-05	0.000312	CcSEcCtD
Trifluoperazine—Triflupromazine—BCHE—epilepsy syndrome	2.56e-05	0.0112	CrCbGaD
Trifluoperazine—Methotrimeprazine—CHRM3—epilepsy syndrome	2.55e-05	0.0111	CrCbGaD
Trifluoperazine—Muscle spasms—Topiramate—epilepsy syndrome	2.54e-05	0.00031	CcSEcCtD
Trifluoperazine—Rash—Carbamazepine—epilepsy syndrome	2.54e-05	0.000309	CcSEcCtD
Trifluoperazine—Dermatitis—Carbamazepine—epilepsy syndrome	2.54e-05	0.000309	CcSEcCtD
Trifluoperazine—Insomnia—Pregabalin—epilepsy syndrome	2.53e-05	0.000308	CcSEcCtD
Trifluoperazine—Nausea—Clonazepam—epilepsy syndrome	2.52e-05	0.000307	CcSEcCtD
Trifluoperazine—Headache—Carbamazepine—epilepsy syndrome	2.52e-05	0.000307	CcSEcCtD
Trifluoperazine—Promethazine—CHRM3—epilepsy syndrome	2.51e-05	0.011	CrCbGaD
Trifluoperazine—Nausea—Phenytoin—epilepsy syndrome	2.5e-05	0.000305	CcSEcCtD
Trifluoperazine—Dyspnoea—Pregabalin—epilepsy syndrome	2.49e-05	0.000304	CcSEcCtD
Trifluoperazine—Nausea—Oxcarbazepine—epilepsy syndrome	2.49e-05	0.000304	CcSEcCtD
Trifluoperazine—Vision blurred—Topiramate—epilepsy syndrome	2.49e-05	0.000303	CcSEcCtD
Trifluoperazine—Skin disorder—Gabapentin—epilepsy syndrome	2.49e-05	0.000303	CcSEcCtD
Trifluoperazine—Trazodone—ADRA2A—epilepsy syndrome	2.49e-05	0.0109	CrCbGaD
Trifluoperazine—Somnolence—Pregabalin—epilepsy syndrome	2.48e-05	0.000303	CcSEcCtD
Trifluoperazine—Tremor—Topiramate—epilepsy syndrome	2.48e-05	0.000302	CcSEcCtD
Trifluoperazine—ABCB1—brain—epilepsy syndrome	2.46e-05	0.000774	CbGeAlD
Trifluoperazine—Loxapine—CHRM3—epilepsy syndrome	2.46e-05	0.0108	CrCbGaD
Trifluoperazine—Urticaria—Valproic Acid—epilepsy syndrome	2.46e-05	0.000299	CcSEcCtD
Trifluoperazine—Rash—Lamotrigine—epilepsy syndrome	2.45e-05	0.000299	CcSEcCtD
Trifluoperazine—Dermatitis—Lamotrigine—epilepsy syndrome	2.45e-05	0.000299	CcSEcCtD
Trifluoperazine—Body temperature increased—Valproic Acid—epilepsy syndrome	2.44e-05	0.000298	CcSEcCtD
Trifluoperazine—Anorexia—Gabapentin—epilepsy syndrome	2.44e-05	0.000298	CcSEcCtD
Trifluoperazine—Headache—Lamotrigine—epilepsy syndrome	2.44e-05	0.000297	CcSEcCtD
Trifluoperazine—Decreased appetite—Pregabalin—epilepsy syndrome	2.43e-05	0.000296	CcSEcCtD
Trifluoperazine—Agitation—Topiramate—epilepsy syndrome	2.43e-05	0.000296	CcSEcCtD
Trifluoperazine—Fatigue—Pregabalin—epilepsy syndrome	2.41e-05	0.000294	CcSEcCtD
Trifluoperazine—Quetiapine—CHRM3—epilepsy syndrome	2.4e-05	0.0105	CrCbGaD
Trifluoperazine—Hypotension—Gabapentin—epilepsy syndrome	2.39e-05	0.000292	CcSEcCtD
Trifluoperazine—Nausea—Carbamazepine—epilepsy syndrome	2.39e-05	0.000291	CcSEcCtD
Trifluoperazine—Constipation—Pregabalin—epilepsy syndrome	2.39e-05	0.000291	CcSEcCtD
Trifluoperazine—Methotrimeprazine—CHRM1—epilepsy syndrome	2.38e-05	0.0104	CrCbGaD
Trifluoperazine—Leukopenia—Topiramate—epilepsy syndrome	2.36e-05	0.000288	CcSEcCtD
Trifluoperazine—Promethazine—CHRM1—epilepsy syndrome	2.34e-05	0.0102	CrCbGaD
Trifluoperazine—Thiothixene—ADRA2A—epilepsy syndrome	2.33e-05	0.0102	CrCbGaD
Trifluoperazine—Insomnia—Gabapentin—epilepsy syndrome	2.32e-05	0.000282	CcSEcCtD
Trifluoperazine—Nausea—Lamotrigine—epilepsy syndrome	2.31e-05	0.000282	CcSEcCtD
Trifluoperazine—Cough—Topiramate—epilepsy syndrome	2.31e-05	0.000281	CcSEcCtD
Trifluoperazine—Loxapine—CHRM1—epilepsy syndrome	2.29e-05	0.01	CrCbGaD
Trifluoperazine—Convulsion—Topiramate—epilepsy syndrome	2.29e-05	0.000279	CcSEcCtD
Trifluoperazine—Dyspnoea—Gabapentin—epilepsy syndrome	2.28e-05	0.000278	CcSEcCtD
Trifluoperazine—Somnolence—Gabapentin—epilepsy syndrome	2.28e-05	0.000278	CcSEcCtD
Trifluoperazine—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.28e-05	0.000278	CcSEcCtD
Trifluoperazine—Propiomazine—CHRM2—epilepsy syndrome	2.27e-05	0.00993	CrCbGaD
Trifluoperazine—Quetiapine—CHRM1—epilepsy syndrome	2.24e-05	0.0098	CrCbGaD
Trifluoperazine—Decreased appetite—Gabapentin—epilepsy syndrome	2.23e-05	0.000272	CcSEcCtD
Trifluoperazine—Urticaria—Pregabalin—epilepsy syndrome	2.22e-05	0.000271	CcSEcCtD
Trifluoperazine—Asthenia—Valproic Acid—epilepsy syndrome	2.22e-05	0.00027	CcSEcCtD
Trifluoperazine—Cyamemazine—HTR2A—epilepsy syndrome	2.21e-05	0.00967	CrCbGaD
Trifluoperazine—Fatigue—Gabapentin—epilepsy syndrome	2.21e-05	0.000269	CcSEcCtD
Trifluoperazine—Body temperature increased—Pregabalin—epilepsy syndrome	2.21e-05	0.000269	CcSEcCtD
Trifluoperazine—Promazine—CHRM3—epilepsy syndrome	2.21e-05	0.00966	CrCbGaD
Trifluoperazine—Dry mouth—Topiramate—epilepsy syndrome	2.2e-05	0.000268	CcSEcCtD
Trifluoperazine—Constipation—Gabapentin—epilepsy syndrome	2.19e-05	0.000267	CcSEcCtD
Trifluoperazine—Pruritus—Valproic Acid—epilepsy syndrome	2.19e-05	0.000267	CcSEcCtD
Trifluoperazine—Skin disorder—Topiramate—epilepsy syndrome	2.09e-05	0.000255	CcSEcCtD
Trifluoperazine—Clozapine—CHRM3—epilepsy syndrome	2.07e-05	0.00904	CrCbGaD
Trifluoperazine—Promazine—CHRM1—epilepsy syndrome	2.06e-05	0.00901	CrCbGaD
Trifluoperazine—Hypersensitivity—Pregabalin—epilepsy syndrome	2.06e-05	0.000251	CcSEcCtD
Trifluoperazine—Anorexia—Topiramate—epilepsy syndrome	2.06e-05	0.00025	CcSEcCtD
Trifluoperazine—Nefazodone—SLC6A4—epilepsy syndrome	2.05e-05	0.00897	CrCbGaD
Trifluoperazine—Dizziness—Valproic Acid—epilepsy syndrome	2.04e-05	0.000249	CcSEcCtD
Trifluoperazine—Urticaria—Gabapentin—epilepsy syndrome	2.04e-05	0.000248	CcSEcCtD
Trifluoperazine—Thioridazine—CHRM2—epilepsy syndrome	2.03e-05	0.00889	CrCbGaD
Trifluoperazine—Body temperature increased—Gabapentin—epilepsy syndrome	2.03e-05	0.000247	CcSEcCtD
Trifluoperazine—Thioridazine—HTR7—epilepsy syndrome	2.02e-05	0.00885	CrCbGaD
Trifluoperazine—Hypotension—Topiramate—epilepsy syndrome	2.01e-05	0.000246	CcSEcCtD
Trifluoperazine—Fluphenazine—ADRA2A—epilepsy syndrome	2.01e-05	0.00881	CrCbGaD
Trifluoperazine—Asthenia—Pregabalin—epilepsy syndrome	2.01e-05	0.000244	CcSEcCtD
Trifluoperazine—Pruritus—Pregabalin—epilepsy syndrome	1.98e-05	0.000241	CcSEcCtD
Trifluoperazine—Insomnia—Topiramate—epilepsy syndrome	1.95e-05	0.000238	CcSEcCtD
Trifluoperazine—Rash—Valproic Acid—epilepsy syndrome	1.95e-05	0.000238	CcSEcCtD
Trifluoperazine—Dermatitis—Valproic Acid—epilepsy syndrome	1.95e-05	0.000237	CcSEcCtD
Trifluoperazine—Chlorpromazine—CHRM3—epilepsy syndrome	1.94e-05	0.0085	CrCbGaD
Trifluoperazine—Methotrimeprazine—CHRM2—epilepsy syndrome	1.94e-05	0.00849	CrCbGaD
Trifluoperazine—Headache—Valproic Acid—epilepsy syndrome	1.94e-05	0.000236	CcSEcCtD
Trifluoperazine—Clozapine—CHRM1—epilepsy syndrome	1.93e-05	0.00843	CrCbGaD
Trifluoperazine—Dyspnoea—Topiramate—epilepsy syndrome	1.92e-05	0.000234	CcSEcCtD
Trifluoperazine—Somnolence—Topiramate—epilepsy syndrome	1.92e-05	0.000234	CcSEcCtD
Trifluoperazine—Promethazine—CHRM2—epilepsy syndrome	1.91e-05	0.00836	CrCbGaD
Trifluoperazine—Trazodone—SLC6A4—epilepsy syndrome	1.9e-05	0.0083	CrCbGaD
Trifluoperazine—Hypersensitivity—Gabapentin—epilepsy syndrome	1.89e-05	0.00023	CcSEcCtD
Trifluoperazine—Decreased appetite—Topiramate—epilepsy syndrome	1.87e-05	0.000228	CcSEcCtD
Trifluoperazine—Loxapine—CHRM2—epilepsy syndrome	1.87e-05	0.0082	CrCbGaD
Trifluoperazine—Loxapine—HTR7—epilepsy syndrome	1.86e-05	0.00816	CrCbGaD
Trifluoperazine—Fatigue—Topiramate—epilepsy syndrome	1.86e-05	0.000227	CcSEcCtD
Trifluoperazine—Perphenazine—HTR7—epilepsy syndrome	1.86e-05	0.00812	CrCbGaD
Trifluoperazine—Dizziness—Pregabalin—epilepsy syndrome	1.85e-05	0.000225	CcSEcCtD
Trifluoperazine—Constipation—Topiramate—epilepsy syndrome	1.84e-05	0.000225	CcSEcCtD
Trifluoperazine—Clomipramine—ADRA2A—epilepsy syndrome	1.84e-05	0.00806	CrCbGaD
Trifluoperazine—Flupentixol—ABCB1—epilepsy syndrome	1.84e-05	0.00805	CrCbGaD
Trifluoperazine—Asthenia—Gabapentin—epilepsy syndrome	1.84e-05	0.000224	CcSEcCtD
Trifluoperazine—Nausea—Valproic Acid—epilepsy syndrome	1.84e-05	0.000224	CcSEcCtD
Trifluoperazine—Quetiapine—CHRM2—epilepsy syndrome	1.83e-05	0.008	CrCbGaD
Trifluoperazine—Quetiapine—HTR7—epilepsy syndrome	1.82e-05	0.00796	CrCbGaD
Trifluoperazine—Pruritus—Gabapentin—epilepsy syndrome	1.81e-05	0.000221	CcSEcCtD
Trifluoperazine—Chlorpromazine—CHRM1—epilepsy syndrome	1.81e-05	0.00793	CrCbGaD
Trifluoperazine—Rash—Pregabalin—epilepsy syndrome	1.76e-05	0.000215	CcSEcCtD
Trifluoperazine—Dermatitis—Pregabalin—epilepsy syndrome	1.76e-05	0.000215	CcSEcCtD
Trifluoperazine—Mequitazine—CYP2D6—epilepsy syndrome	1.76e-05	0.00768	CrCbGaD
Trifluoperazine—Headache—Pregabalin—epilepsy syndrome	1.75e-05	0.000213	CcSEcCtD
Trifluoperazine—Thioridazine—ADRA2A—epilepsy syndrome	1.73e-05	0.00759	CrCbGaD
Trifluoperazine—Urticaria—Topiramate—epilepsy syndrome	1.71e-05	0.000209	CcSEcCtD
Trifluoperazine—Body temperature increased—Topiramate—epilepsy syndrome	1.7e-05	0.000208	CcSEcCtD
Trifluoperazine—Dizziness—Gabapentin—epilepsy syndrome	1.69e-05	0.000207	CcSEcCtD
Trifluoperazine—Pipotiazine—CYP2C19—epilepsy syndrome	1.68e-05	0.00737	CrCbGaD
Trifluoperazine—Promazine—CHRM2—epilepsy syndrome	1.68e-05	0.00736	CrCbGaD
Trifluoperazine—Nausea—Pregabalin—epilepsy syndrome	1.66e-05	0.000202	CcSEcCtD
Trifluoperazine—Methotrimeprazine—ADRA2A—epilepsy syndrome	1.66e-05	0.00725	CrCbGaD
Trifluoperazine—Rash—Gabapentin—epilepsy syndrome	1.62e-05	0.000197	CcSEcCtD
Trifluoperazine—Dermatitis—Gabapentin—epilepsy syndrome	1.61e-05	0.000197	CcSEcCtD
Trifluoperazine—Headache—Gabapentin—epilepsy syndrome	1.61e-05	0.000196	CcSEcCtD
Trifluoperazine—Loxapine—ADRA2A—epilepsy syndrome	1.6e-05	0.007	CrCbGaD
Trifluoperazine—Perphenazine—ADRA2A—epilepsy syndrome	1.59e-05	0.00697	CrCbGaD
Trifluoperazine—Hypersensitivity—Topiramate—epilepsy syndrome	1.59e-05	0.000194	CcSEcCtD
Trifluoperazine—Zuclopenthixol—HTR2A—epilepsy syndrome	1.58e-05	0.00693	CrCbGaD
Trifluoperazine—Nefazodone—HTR2A—epilepsy syndrome	1.57e-05	0.00689	CrCbGaD
Trifluoperazine—Clozapine—CHRM2—epilepsy syndrome	1.57e-05	0.00688	CrCbGaD
Trifluoperazine—Clozapine—HTR7—epilepsy syndrome	1.57e-05	0.00685	CrCbGaD
Trifluoperazine—Quetiapine—ADRA2A—epilepsy syndrome	1.56e-05	0.00683	CrCbGaD
Trifluoperazine—Asthenia—Topiramate—epilepsy syndrome	1.55e-05	0.000189	CcSEcCtD
Trifluoperazine—Pruritus—Topiramate—epilepsy syndrome	1.53e-05	0.000186	CcSEcCtD
Trifluoperazine—Nausea—Gabapentin—epilepsy syndrome	1.52e-05	0.000186	CcSEcCtD
Trifluoperazine—Chlorpromazine—CHRM2—epilepsy syndrome	1.48e-05	0.00647	CrCbGaD
Trifluoperazine—Chlorpromazine—HTR7—epilepsy syndrome	1.47e-05	0.00644	CrCbGaD
Trifluoperazine—Trazodone—HTR2A—epilepsy syndrome	1.46e-05	0.00638	CrCbGaD
Trifluoperazine—Zuclopenthixol—CYP2D6—epilepsy syndrome	1.45e-05	0.00634	CrCbGaD
Trifluoperazine—Nefazodone—CYP2D6—epilepsy syndrome	1.44e-05	0.0063	CrCbGaD
Trifluoperazine—Promazine—ADRA2A—epilepsy syndrome	1.43e-05	0.00628	CrCbGaD
Trifluoperazine—Dizziness—Topiramate—epilepsy syndrome	1.43e-05	0.000174	CcSEcCtD
Trifluoperazine—Acepromazine—HTR2A—epilepsy syndrome	1.42e-05	0.00621	CrCbGaD
Trifluoperazine—Clomipramine—SLC6A4—epilepsy syndrome	1.4e-05	0.00615	CrCbGaD
Trifluoperazine—Thioproperazine—HTR2A—epilepsy syndrome	1.39e-05	0.00607	CrCbGaD
Trifluoperazine—Thiothixene—HTR2A—epilepsy syndrome	1.37e-05	0.00598	CrCbGaD
Trifluoperazine—Pipotiazine—HTR2A—epilepsy syndrome	1.37e-05	0.00598	CrCbGaD
Trifluoperazine—Rash—Topiramate—epilepsy syndrome	1.36e-05	0.000166	CcSEcCtD
Trifluoperazine—Dermatitis—Topiramate—epilepsy syndrome	1.36e-05	0.000166	CcSEcCtD
Trifluoperazine—Headache—Topiramate—epilepsy syndrome	1.35e-05	0.000165	CcSEcCtD
Trifluoperazine—Mesoridazine—HTR2A—epilepsy syndrome	1.35e-05	0.0059	CrCbGaD
Trifluoperazine—Clozapine—ADRA2A—epilepsy syndrome	1.34e-05	0.00588	CrCbGaD
Trifluoperazine—Trazodone—CYP2D6—epilepsy syndrome	1.33e-05	0.00583	CrCbGaD
Trifluoperazine—Clomipramine—CYP2C19—epilepsy syndrome	1.33e-05	0.00583	CrCbGaD
Trifluoperazine—Nausea—Topiramate—epilepsy syndrome	1.28e-05	0.000156	CcSEcCtD
Trifluoperazine—Chlorpromazine—ADRA2A—epilepsy syndrome	1.26e-05	0.00553	CrCbGaD
Trifluoperazine—Thioridazine—CYP2C19—epilepsy syndrome	1.25e-05	0.00549	CrCbGaD
Trifluoperazine—Pipotiazine—CYP2D6—epilepsy syndrome	1.25e-05	0.00546	CrCbGaD
Trifluoperazine—Thiothixene—CYP2D6—epilepsy syndrome	1.25e-05	0.00546	CrCbGaD
Trifluoperazine—Chlorpromazine—BCHE—epilepsy syndrome	1.23e-05	0.0054	CrCbGaD
Trifluoperazine—Mesoridazine—CYP2D6—epilepsy syndrome	1.23e-05	0.00539	CrCbGaD
Trifluoperazine—Loxapine—SLC6A4—epilepsy syndrome	1.22e-05	0.00534	CrCbGaD
Trifluoperazine—Prochlorperazine—CYP2D6—epilepsy syndrome	1.19e-05	0.00522	CrCbGaD
Trifluoperazine—Fluphenazine—HTR2A—epilepsy syndrome	1.18e-05	0.00516	CrCbGaD
Trifluoperazine—Perphenazine—CYP2C19—epilepsy syndrome	1.15e-05	0.00504	CrCbGaD
Trifluoperazine—Propiomazine—HTR2A—epilepsy syndrome	1.14e-05	0.00497	CrCbGaD
Trifluoperazine—Quetiapine—CYP2C19—epilepsy syndrome	1.13e-05	0.00494	CrCbGaD
Trifluoperazine—Clomipramine—HTR2A—epilepsy syndrome	1.08e-05	0.00472	CrCbGaD
Trifluoperazine—Fluphenazine—CYP2D6—epilepsy syndrome	1.08e-05	0.00472	CrCbGaD
Trifluoperazine—Promazine—CYP2C19—epilepsy syndrome	1.04e-05	0.00454	CrCbGaD
Trifluoperazine—Nefazodone—ABCB1—epilepsy syndrome	1.03e-05	0.0045	CrCbGaD
Trifluoperazine—Thioridazine—HTR2A—epilepsy syndrome	1.02e-05	0.00445	CrCbGaD
Trifluoperazine—Triflupromazine—ABCB1—epilepsy syndrome	1e-05	0.00439	CrCbGaD
Trifluoperazine—Clomipramine—CYP2D6—epilepsy syndrome	9.87e-06	0.00432	CrCbGaD
Trifluoperazine—Acepromazine—ALB—epilepsy syndrome	9.72e-06	0.00425	CrCbGaD
Trifluoperazine—Clozapine—CYP2C19—epilepsy syndrome	9.71e-06	0.00425	CrCbGaD
Trifluoperazine—Methotrimeprazine—HTR2A—epilepsy syndrome	9.71e-06	0.00425	CrCbGaD
Trifluoperazine—Promethazine—HTR2A—epilepsy syndrome	9.56e-06	0.00418	CrCbGaD
Trifluoperazine—Trazodone—ABCB1—epilepsy syndrome	9.52e-06	0.00416	CrCbGaD
Trifluoperazine—Thioproperazine—ALB—epilepsy syndrome	9.5e-06	0.00416	CrCbGaD
Trifluoperazine—Loxapine—HTR2A—epilepsy syndrome	9.38e-06	0.0041	CrCbGaD
Trifluoperazine—Pipotiazine—ALB—epilepsy syndrome	9.34e-06	0.00409	CrCbGaD
Trifluoperazine—Thiothixene—ALB—epilepsy syndrome	9.34e-06	0.00409	CrCbGaD
Trifluoperazine—Perphenazine—HTR2A—epilepsy syndrome	9.33e-06	0.00408	CrCbGaD
Trifluoperazine—Thioridazine—CYP2D6—epilepsy syndrome	9.3e-06	0.00407	CrCbGaD
Trifluoperazine—Quetiapine—HTR2A—epilepsy syndrome	9.15e-06	0.004	CrCbGaD
Trifluoperazine—Methotrimeprazine—CYP2D6—epilepsy syndrome	8.88e-06	0.00388	CrCbGaD
Trifluoperazine—Promethazine—CYP2D6—epilepsy syndrome	8.74e-06	0.00383	CrCbGaD
Trifluoperazine—Perphenazine—CYP2D6—epilepsy syndrome	8.53e-06	0.00373	CrCbGaD
Trifluoperazine—Promazine—HTR2A—epilepsy syndrome	8.41e-06	0.00368	CrCbGaD
Trifluoperazine—Quetiapine—CYP2D6—epilepsy syndrome	8.37e-06	0.00366	CrCbGaD
Trifluoperazine—Clozapine—HTR2A—epilepsy syndrome	7.87e-06	0.00344	CrCbGaD
Trifluoperazine—Fluphenazine—ABCB1—epilepsy syndrome	7.71e-06	0.00337	CrCbGaD
Trifluoperazine—Chlorpromazine—HTR2A—epilepsy syndrome	7.4e-06	0.00324	CrCbGaD
Trifluoperazine—Clomipramine—ALB—epilepsy syndrome	7.39e-06	0.00323	CrCbGaD
Trifluoperazine—Clozapine—CYP2D6—epilepsy syndrome	7.2e-06	0.00315	CrCbGaD
Trifluoperazine—Clomipramine—ABCB1—epilepsy syndrome	7.05e-06	0.00308	CrCbGaD
Trifluoperazine—Chlorpromazine—CYP2D6—epilepsy syndrome	6.77e-06	0.00296	CrCbGaD
Trifluoperazine—Promethazine—ABCB1—epilepsy syndrome	6.24e-06	0.00273	CrCbGaD
Trifluoperazine—Quetiapine—ABCB1—epilepsy syndrome	5.98e-06	0.00261	CrCbGaD
Trifluoperazine—Clozapine—ABCB1—epilepsy syndrome	5.14e-06	0.00225	CrCbGaD
Trifluoperazine—Chlorpromazine—ALB—epilepsy syndrome	5.07e-06	0.00222	CrCbGaD
Trifluoperazine—Chlorpromazine—ABCB1—epilepsy syndrome	4.83e-06	0.00212	CrCbGaD
Trifluoperazine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	7.19e-07	1.26e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—H2AFX—epilepsy syndrome	7.18e-07	1.26e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—H2AFX—epilepsy syndrome	7.18e-07	1.26e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MEF2C—epilepsy syndrome	7.17e-07	1.26e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MEF2C—epilepsy syndrome	7.17e-07	1.26e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—YWHAZ—epilepsy syndrome	7.16e-07	1.26e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—FGF2—epilepsy syndrome	7.12e-07	1.25e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—FGF2—epilepsy syndrome	7.12e-07	1.25e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	7.12e-07	1.25e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	7.11e-07	1.25e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	7.1e-07	1.25e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—MMP9—epilepsy syndrome	7.09e-07	1.24e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	7.09e-07	1.24e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—TH—epilepsy syndrome	7.08e-07	1.24e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NGF—epilepsy syndrome	7.08e-07	1.24e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	7.07e-07	1.24e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—BCL2—epilepsy syndrome	6.99e-07	1.23e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	6.99e-07	1.23e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.97e-07	1.22e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	6.97e-07	1.22e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	6.96e-07	1.22e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	6.94e-07	1.22e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—YWHAZ—epilepsy syndrome	6.93e-07	1.22e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—YWHAZ—epilepsy syndrome	6.93e-07	1.22e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCR5—epilepsy syndrome	6.89e-07	1.21e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—AKT1—epilepsy syndrome	6.88e-07	1.21e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NGF—epilepsy syndrome	6.85e-07	1.2e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NGF—epilepsy syndrome	6.85e-07	1.2e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—RELA—epilepsy syndrome	6.83e-07	1.2e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—FGF2—epilepsy syndrome	6.8e-07	1.19e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—BCL2—epilepsy syndrome	6.76e-07	1.19e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—BCL2—epilepsy syndrome	6.76e-07	1.19e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—HTR2A—epilepsy syndrome	6.74e-07	1.18e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—MTOR—epilepsy syndrome	6.7e-07	1.18e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCR5—epilepsy syndrome	6.66e-07	1.17e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCR5—epilepsy syndrome	6.66e-07	1.17e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	6.64e-07	1.16e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—RELA—epilepsy syndrome	6.61e-07	1.16e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—RELA—epilepsy syndrome	6.61e-07	1.16e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—GPX1—epilepsy syndrome	6.61e-07	1.16e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	6.6e-07	1.16e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	6.59e-07	1.16e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—FGF2—epilepsy syndrome	6.57e-07	1.15e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—FGF2—epilepsy syndrome	6.57e-07	1.15e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—SRC—epilepsy syndrome	6.54e-07	1.15e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HTR2A—epilepsy syndrome	6.52e-07	1.14e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HTR2A—epilepsy syndrome	6.52e-07	1.14e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	6.48e-07	1.14e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—MTOR—epilepsy syndrome	6.48e-07	1.14e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—MTOR—epilepsy syndrome	6.48e-07	1.14e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	6.47e-07	1.14e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	6.45e-07	1.13e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—POMC—epilepsy syndrome	6.44e-07	1.13e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TSC2—epilepsy syndrome	6.4e-07	1.12e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AGT—epilepsy syndrome	6.39e-07	1.12e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	6.37e-07	1.12e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	6.37e-07	1.12e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—AKT1—epilepsy syndrome	6.36e-07	1.12e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	6.35e-07	1.11e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	6.34e-07	1.11e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	6.33e-07	1.11e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—APOE—epilepsy syndrome	6.26e-07	1.1e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	6.23e-07	1.09e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—POMC—epilepsy syndrome	6.23e-07	1.09e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—POMC—epilepsy syndrome	6.23e-07	1.09e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	6.21e-07	1.09e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TSC2—epilepsy syndrome	6.19e-07	1.09e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TSC2—epilepsy syndrome	6.19e-07	1.09e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MTOR—epilepsy syndrome	6.19e-07	1.09e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AGT—epilepsy syndrome	6.19e-07	1.09e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AGT—epilepsy syndrome	6.19e-07	1.09e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL1B—epilepsy syndrome	6.18e-07	1.08e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	6.16e-07	1.08e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—AKT1—epilepsy syndrome	6.16e-07	1.08e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—AKT1—epilepsy syndrome	6.16e-07	1.08e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—KDR—epilepsy syndrome	6.14e-07	1.08e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PTGS2—epilepsy syndrome	6.13e-07	1.08e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	6.13e-07	1.08e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—APOE—epilepsy syndrome	6.06e-07	1.06e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—APOE—epilepsy syndrome	6.06e-07	1.06e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	6.04e-07	1.06e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	6.01e-07	1.05e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—JUN—epilepsy syndrome	5.99e-07	1.05e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MTOR—epilepsy syndrome	5.98e-07	1.05e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MTOR—epilepsy syndrome	5.98e-07	1.05e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL1B—epilepsy syndrome	5.98e-07	1.05e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL1B—epilepsy syndrome	5.98e-07	1.05e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—KDR—epilepsy syndrome	5.94e-07	1.04e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—KDR—epilepsy syndrome	5.94e-07	1.04e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PTGS2—epilepsy syndrome	5.93e-07	1.04e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PTGS2—epilepsy syndrome	5.93e-07	1.04e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	5.91e-07	1.04e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PRKCB—epilepsy syndrome	5.91e-07	1.04e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6ST—epilepsy syndrome	5.88e-07	1.03e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—ALB—epilepsy syndrome	5.87e-07	1.03e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CAT—epilepsy syndrome	5.83e-07	1.02e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	5.83e-07	1.02e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—AGT—epilepsy syndrome	5.8e-07	1.02e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—JUN—epilepsy syndrome	5.79e-07	1.02e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—JUN—epilepsy syndrome	5.79e-07	1.02e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	5.73e-07	1.01e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—AKT1—epilepsy syndrome	5.73e-07	1.01e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	5.72e-07	1e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PRKCB—epilepsy syndrome	5.72e-07	1e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PRKCB—epilepsy syndrome	5.72e-07	1e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6ST—epilepsy syndrome	5.69e-07	9.99e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6ST—epilepsy syndrome	5.69e-07	9.99e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—APOE—epilepsy syndrome	5.68e-07	9.96e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—ALB—epilepsy syndrome	5.68e-07	9.96e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—ALB—epilepsy syndrome	5.68e-07	9.96e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	5.68e-07	9.96e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	5.63e-07	9.88e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	5.61e-07	9.85e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	5.61e-07	9.84e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	5.58e-07	9.79e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	5.56e-07	9.75e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—AKT1—epilepsy syndrome	5.54e-07	9.73e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—AKT1—epilepsy syndrome	5.54e-07	9.73e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	5.53e-07	9.7e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—AKT1—epilepsy syndrome	5.5e-07	9.65e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	5.41e-07	9.49e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	5.4e-07	9.47e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—POMC—epilepsy syndrome	5.38e-07	9.44e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—SRC—epilepsy syndrome	5.37e-07	9.42e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	5.37e-07	9.42e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—AKT1—epilepsy syndrome	5.32e-07	9.34e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—AKT1—epilepsy syndrome	5.32e-07	9.34e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	5.32e-07	9.34e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	5.31e-07	9.32e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	5.3e-07	9.31e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	5.28e-07	9.26e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCL2—epilepsy syndrome	5.27e-07	9.24e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	5.25e-07	9.21e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	5.23e-07	9.17e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	5.22e-07	9.17e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	5.22e-07	9.16e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	5.21e-07	9.14e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	5.21e-07	9.14e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—POMC—epilepsy syndrome	5.21e-07	9.14e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—POMC—epilepsy syndrome	5.21e-07	9.14e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—SRC—epilepsy syndrome	5.19e-07	9.12e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—SRC—epilepsy syndrome	5.19e-07	9.12e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PTGS2—epilepsy syndrome	5.13e-07	9.01e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	5.12e-07	8.99e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	5.11e-07	8.97e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCL2—epilepsy syndrome	5.09e-07	8.94e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCL2—epilepsy syndrome	5.09e-07	8.94e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	5.09e-07	8.94e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	5.07e-07	8.89e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTGS2—epilepsy syndrome	4.97e-07	8.71e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTGS2—epilepsy syndrome	4.97e-07	8.71e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—SRC—epilepsy syndrome	4.96e-07	8.7e-06	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	4.92e-07	8.64e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	4.88e-07	8.56e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—POMC—epilepsy syndrome	4.88e-07	8.56e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.85e-07	8.5e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	4.84e-07	8.5e-06	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.83e-07	8.48e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	4.82e-07	8.45e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	4.8e-07	8.42e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—SRC—epilepsy syndrome	4.8e-07	8.42e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—SRC—epilepsy syndrome	4.8e-07	8.42e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	4.79e-07	8.41e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—FGF2—epilepsy syndrome	4.76e-07	8.35e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	4.76e-07	8.35e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.74e-07	8.32e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	4.74e-07	8.32e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	4.72e-07	8.27e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	4.71e-07	8.27e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	4.7e-07	8.25e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	4.69e-07	8.23e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	4.66e-07	8.18e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	4.65e-07	8.16e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AGT—epilepsy syndrome	4.63e-07	8.12e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	4.61e-07	8.09e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—FGF2—epilepsy syndrome	4.6e-07	8.08e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—FGF2—epilepsy syndrome	4.6e-07	8.08e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	4.58e-07	8.03e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	4.57e-07	8.01e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	4.54e-07	7.96e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—APOE—epilepsy syndrome	4.53e-07	7.95e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	4.53e-07	7.94e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	4.47e-07	7.85e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	4.45e-07	7.82e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—ALB—epilepsy syndrome	4.45e-07	7.8e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	4.44e-07	7.79e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—RELA—epilepsy syndrome	4.42e-07	7.75e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	4.4e-07	7.72e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	4.39e-07	7.7e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MTOR—epilepsy syndrome	4.33e-07	7.6e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	4.32e-07	7.58e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	4.31e-07	7.56e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—RELA—epilepsy syndrome	4.27e-07	7.5e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—RELA—epilepsy syndrome	4.27e-07	7.5e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	4.25e-07	7.46e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MTOR—epilepsy syndrome	4.19e-07	7.35e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MTOR—epilepsy syndrome	4.19e-07	7.35e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	4.18e-07	7.34e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	4.17e-07	7.32e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	4.14e-07	7.26e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	4.11e-07	7.21e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	4.1e-07	7.19e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	4.07e-07	7.15e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	4.06e-07	7.13e-06	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	4.06e-07	7.13e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	4e-07	7.02e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	3.99e-07	7e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CASP3—epilepsy syndrome	3.98e-07	6.99e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—POMC—epilepsy syndrome	3.89e-07	6.83e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	3.89e-07	6.83e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—JUN—epilepsy syndrome	3.87e-07	6.79e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CASP3—epilepsy syndrome	3.85e-07	6.76e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CASP3—epilepsy syndrome	3.85e-07	6.76e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MMP9—epilepsy syndrome	3.77e-07	6.61e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—JUN—epilepsy syndrome	3.74e-07	6.57e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—JUN—epilepsy syndrome	3.74e-07	6.57e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—AKT1—epilepsy syndrome	3.65e-07	6.41e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MMP9—epilepsy syndrome	3.64e-07	6.39e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MMP9—epilepsy syndrome	3.64e-07	6.39e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ALB—epilepsy syndrome	3.55e-07	6.23e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—AKT1—epilepsy syndrome	3.53e-07	6.2e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—AKT1—epilepsy syndrome	3.53e-07	6.2e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SRC—epilepsy syndrome	3.47e-07	6.09e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VEGFA—epilepsy syndrome	3.38e-07	5.93e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SRC—epilepsy syndrome	3.36e-07	5.89e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SRC—epilepsy syndrome	3.36e-07	5.89e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—AKT1—epilepsy syndrome	3.34e-07	5.86e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VEGFA—epilepsy syndrome	3.27e-07	5.74e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VEGFA—epilepsy syndrome	3.27e-07	5.74e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—AKT1—epilepsy syndrome	3.23e-07	5.66e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—AKT1—epilepsy syndrome	3.23e-07	5.66e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	3.11e-07	5.45e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—AKT1—epilepsy syndrome	3.08e-07	5.41e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	3.01e-07	5.28e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	2.99e-07	5.25e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—AKT1—epilepsy syndrome	2.98e-07	5.23e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—AKT1—epilepsy syndrome	2.98e-07	5.23e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	2.64e-07	4.64e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	2.6e-07	4.56e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	2.59e-07	4.55e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—AKT1—epilepsy syndrome	2.58e-07	4.53e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	2.55e-07	4.48e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	2.54e-07	4.47e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—AKT1—epilepsy syndrome	2.5e-07	4.38e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—AKT1—epilepsy syndrome	2.5e-07	4.38e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKT1—epilepsy syndrome	2.16e-07	3.79e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKT1—epilepsy syndrome	2.09e-07	3.66e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKT1—epilepsy syndrome	2.09e-07	3.66e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.96e-07	3.43e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.56e-07	2.74e-06	CbGpPWpGaD
